What Is The Leading Driver Behind The Surge Of Population Screening In Addressing The Growing Cancer Burden Market Expansion in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Population Screening Industry Market Size Be by 2025?
The domain of population screening has experienced robust expansion lately, projected to increase its market valuation from $29.31 billion in the year 2024 to $31.39 billion by 2025, reflecting a compound annual growth rate (CAGR) of 7.1%; this upward trajectory during the past period is underpinned by factors such as disease prevention programs being implemented, supportive governmental health regulations, the escalating expense of medical care, and heightened public consciousness regarding various ailments.

What's the Long-Term Growth Forecast for the Population Screening Market Size Through 2029?
Anticipation surrounds the population screening sector, projecting robust expansion in the forthcoming years, where the market valuation is set to reach $41.4 billion by 2029, propelled by a compound annual growth rate (CAGR) of 7.2%. This surge throughout the projection timeframe is fundamentally driven by several key factors, namely the increasing pivot towards individualized medical treatments, the demographic effect of an aging populace grappling with persistent ailments, the seamless incorporation of artificial intelligence and sophisticated data analysis tools, and a broadened availability of screening opportunities. Concurrently, the principal currents shaping this market will involve forward strides in medical instrument development, the convergence of genetics and highly accurate screening methodologies, the rising adoption of virtual healthcare and remote diagnostic practices, the implementation of comprehensive panels designed to detect multiple conditions simultaneously, and a concentrated effort on achieving fairness and ease of access in healthcare delivery.

View the full report here:
https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

What Are the Key Growth Drivers Fueling the Population Screening Market Expansion?
The escalating occurrence of cancer is anticipated to fuel the expansion of the population screening sector in the foreseeable future.Cancer, characterized by the abnormal proliferation and dissemination of particular human cells throughout the body, warrants early detection through population screening initiatives, which significantly enhance treatability and patient outlook.Evidence supporting this trend includes data from the American Cancer Society Inc., a US-based non-profit organization, which indicated that in 2022, there were an estimated 1.9 million new cancer diagnoses alongside 608,570 fatalities, contrasting with 606,520 deaths recorded in 2021; consequently, this increasing incidence of cancer serves as a major catalyst for the growth trajectory of the population screening market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

What Are the Key Trends Driving Population Screening Market Growth?
Major companies operating in the population screening market are innovating advanced services, such as newborn mass screening, to enhance early detection and improve infant health outcomes. Newborn mass screening is a public health program where newborns are tested shortly after birth for a range of genetic, metabolic, hormonal, and functional disorders that are not apparent at birth but can lead to severe health problems if left untreated. For instance, in May 2024, Shimadzu Techno-Research Inc., a contract analysis company and subsidiary of Shimadzu Corporation, a Japan-based manufacturer of precision instruments, launched a new contract service that performs polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will screen for combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), which currently affect a small percentage of newborns but require immediate intervention upon diagnosis.

How Is the Population Screening Market Segmented?
The population screeningmarket covered in this report is segmented -

1) By Product: Hardware Equipment; Testing Or Lab; Analytics Or Interpretation
2) By Gender: Male; Female
3) By Age: Ages Less Than 15; 15-65; Ages 65 And Above
4) By Business: Hospitals; Research Institutes; Diagnostic Labs

Subsegments:
1) By Hardware Equipment: Diagnostic Devices; Sample Collection Devices; Imaging Equipment
2) By Testing Or Lab: Laboratory Testing Kits; Point-Of-Care Testing; Blood And Urine Testing Services
3) By Analytics Or Interpretation: Software Solutions For Data Analysis; Interpretation Services; Reporting Tools

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

Which Companies Are Leading the Charge in Population Screening Market Innovation?
Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

Which Regions Are Leading the Global Population Screening Market in Revenue?
North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12587

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.